Regencell Bioscience Faces Securities Class Action Lawsuit

Investors in Regencell Bioscience Holdings Limited (NASDAQ: RGC) have until June 23, 2026, to seek a leadership role in a securities class action lawsuit against the company.

4 May, 17:12 — 4 May, 17:12

Post Share

Sources

Showing 1 of 1 sources

globe-and-mailHigh5h ago

Regencell Bioscience Holdings Limited (NASDAQ: RGC) Investors Have Until June 23, 2026 to Seek a Leadership Role in the Securities Class Action Lawsuit Contact Kaplan Fox & Kilsheimer LLP - The Globe and Mail

Regencell Bioscience Holdings Limited (NASDAQ: RGC) Investors Have Until June 23, 2026 to Seek a Leadership Role in the Securities Class Action Lawsuit Contact Kaplan Fox & Kilsheimer LLP The Globe and Mail

Read full article →

PERSPECTA

PERSPECTA

Regencell Bioscience Faces Securities Class Action Lawsuit

Sources

Regencell Bioscience Holdings Limited (NASDAQ: RGC) Investors Have Until June 23, 2026 to Seek a Leadership Role in the Securities Class Action Lawsuit Contact Kaplan Fox & Kilsheimer LLP - The Globe and Mail

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

Philippines Opens New Calax Expressway Section

New Philippine General Hospital to be Built in Cavite

Philippine Senate Bill Seeks Removal of VAT on Electricity System Loss

PERSPECTA